跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AZACITIDINE FOR INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AZACITIDINE FOR INJECTION
Authorized
STANDARD
AZACITIDINE FOR INJECTION
hikma canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
7fda1fa4596af052
Company
hikma canada limited
Type
Standard
Approval Details
Approval Id
7fda1fa4596af052
Drug Approval Canada Name
AZACITIDINE FOR INJECTION
Product Name
AZACITIDINE FOR INJECTION
Status
Marketed
Status Date
2022-02-24
Original Market Date
2022-02-24
Din
02507668
Drug Class
Human
Dosage Form
Powder For Suspension
Route Of Administration
Subcutaneous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01BC07 AZACITIDINE
Atc Name
l 01 bc 07
Aig Number
0152665001
Company Name
hikma canada limited
Company Address
5995 Avebury Road, Suite 804, Mississauga, Ontario, Canada, L5R 3P9
Active Ingredients
AZACITIDINE
100 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
7fda1fa4596af052
Type
Standard
Back to Health Canada Approvals